The safety and effectiveness of single-pass erbium:YAG laser in the treatment of mild to moderate photodamage.
BACKGROUND
There are several treatment modalities for mild to moderate photodamage. The demand for effective treatments with minimal side effects has increased.


OBJECTIVE
The objective of this study was to determine the effectiveness of short-pulsed erbium:YAG laser in treating mild to moderate photodamage.


METHODS
Twenty patients were treated with the short-pulse erbium:YAG laser on the face and neck. One pass was given over the entire face with two to three passes over the perioral and periorbital regions. Patients were evaluated for improvement of pigmentary irregularities, skin texture, and fine wrinkles. All side effects were recorded at follow-up visits. Two lasers were used, Sciton and Cynosure CO3, under local anesthesia.


RESULTS
There was a 58% reduction in pigment irregularities and a 54% improvement in skin texture. There was minimal improvement in fine wrinkles with one pass. Two and three passes resulted in a 50% reduction in wrinkles. The procedure was minimally painful. Side effects included 3 to 5 days of erythema and edema. Patients returned to work within 3 days on average. There were no infections. Patient satisfaction with the procedure was rated as very good. There was no difference in efficacy or adverse effects with either laser.


CONCLUSIONS
One-pass short-pulse erbium:YAG laser in treating photodamage of the face and neck is safe and effective. There are minimal side effects and patients heal within 3 to 5 days.
Avram
David K
DK
Dermatology/Cosmetic Laser Associates of La Jolla, La Jolla, California 92037, USA.
Goldman
Mitchel P
MP
D004871:Erbium; D005148:Facial Dermatoses / Q000473:pathology / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D028022:Low-Level Light Therapy; D008875:Middle Aged; D009333:Neck; D012720:Severity of Illness Index; D015595:Skin Aging / Q000473:pathology / Q000528:radiation effects*; D016896:Treatment Outcome
D004871:Erbium